Lifecycle tissue engineering: An AI-enabled multimodal sensing and digital twin roadmap

The clinical translation of tissue engineering (TE) is critically hampered by the absence of real-time, non-invasive monitoring throughout the entire lifecycle of tissue fabrication and repair. Current reliance on end-point assessments obscures dynamic biological events, making early detection of deviations and failures challenging. While multimodal sensing offers rich data streams, inherent issues such as long-term drift, noise accumulation, and difficulties in cross-modality comparability impede their transformation into reliable process metrics and actionable insights. This review introduces a novel, comprehensive four-layer framework consisting of Problem, Data, Model, and Application Evidence, to systematically integrate artificial intelligence (AI)-enabled multimodal sensing across the full TE lifecycle. The Problem Layer delineates critical biological uncertainties and monitoring requirements. The Data Layer surveys diverse in vitro and in vivo observables, sensing modalities, and readout strategies. The Model Layer bridges data acquisition with decision-making, emphasizing AI's role in signal processing, feature extraction, data fusion, and predictive analytics for early failure identification and outcome prediction. The Application Evidence Layer synthesizes current evidence, showcasing AI and sensing applications in donor or cell screening, in vitro process optimization, post-implantation quantitative readout, longitudinal assessment, and diagnostic prediction. This framework moves beyond fragmented approaches by proposing a unified architecture for lifecycle TE, addressing a significant gap in existing literature. We further delineate a strategic roadmap for clinical translation, underscoring the imperative for standardization, long-term reliability, unified evaluation protocols, and responsible AI development. By distinguishing demonstrated technologies from integration steps that remain conceptual or require TE-specific validation, this review outlines a structured roadmap for moving TE monitoring from isolated readouts toward more predictive, traceable, and verifiable translational workflows.

Authors

Institutions

Publication Details

Journal
Bioactive Materials
Published
2026-10-27
DOI
https://doi.org/10.1016/j.bioactmat.2026.06.044
Primary Topic
Tissue Engineering and Regenerative Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lifecycle tissue engineering: An AI-enabled multimodal sensing and digital twin roadmap

Malcolm M. Q. Xing, Lewei Tu, Xing Liu, Yeqin Yang et al.
1 links
Bioactive Materials
Tissue Engineering and Regenerative Medicine
article

Lifecycle tissue engineering: An AI-enabled multimodal sensing and digital twin roadmap

Malcolm M. Q. Xing, Lewei Tu, Xing Liu, Yeqin Yang, Jingjing Gu, Xiaoxuan Zhao, Yitao Zhou, Cuiyi Wang, Qiuhua Sun
article en

Abstract

The clinical translation of tissue engineering (TE) is critically hampered by the absence of real-time, non-invasive monitoring throughout the entire lifecycle of tissue fabrication and repair. Current reliance on end-point assessments obscures dynamic biological events, making early detection of deviations and failures challenging. While multimodal sensing offers rich data streams, inherent issues such as long-term drift, noise accumulation, and difficulties in cross-modality comparability impede their transformation into reliable process metrics and actionable insights. This review introduces a novel, comprehensive four-layer framework consisting of Problem, Data, Model, and Application Evidence, to systematically integrate artificial intelligence (AI)-enabled multimodal sensing across the full TE lifecycle. The Problem Layer delineates critical biological uncertainties and monitoring requirements. The Data Layer surveys diverse in vitro and in vivo observables, sensing modalities, and readout strategies. The Model Layer bridges data acquisition with decision-making, emphasizing AI's role in signal processing, feature extraction, data fusion, and predictive analytics for early failure identification and outcome prediction. The Application Evidence Layer synthesizes current evidence, showcasing AI and sensing applications in donor or cell screening, in vitro process optimization, post-implantation quantitative readout, longitudinal assessment, and diagnostic prediction. This framework moves beyond fragmented approaches by proposing a unified architecture for lifecycle TE, addressing a significant gap in existing literature. We further delineate a strategic roadmap for clinical translation, underscoring the imperative for standardization, long-term reliability, unified evaluation protocols, and responsible AI development. By distinguishing demonstrated technologies from integration steps that remain conceptual or require TE-specific validation, this review outlines a structured roadmap for moving TE monitoring from isolated readouts toward more predictive, traceable, and verifiable translational workflows.

Bioactive MaterialsVol. 67
Zhejiang Chinese Medical University (CN), University of Manitoba (CA)
Openalex Percentile: Top 10%
Tissue Engineering and Regenerative Medicine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon